Cross Country Healthcare (CCRN) Competitors $12.53 -0.57 (-4.35%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$12.51 -0.02 (-0.16%) As of 08/7/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CCRN vs. NVEE, AMN, MD, LH, DGX, DVA, CHE, CRVL, AMED, and NSPShould you be buying Cross Country Healthcare stock or one of its competitors? The main competitors of Cross Country Healthcare include NV5 Global (NVEE), AMN Healthcare Services (AMN), Pediatrix Medical Group (MD), Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), and Insperity (NSP). Cross Country Healthcare vs. Its Competitors NV5 Global AMN Healthcare Services Pediatrix Medical Group Labcorp Quest Diagnostics DaVita Chemed CorVel Amedisys Insperity NV5 Global (NASDAQ:NVEE) and Cross Country Healthcare (NASDAQ:CCRN) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation. Does the media refer more to NVEE or CCRN? In the previous week, NV5 Global and NV5 Global both had 8 articles in the media. NV5 Global's average media sentiment score of 0.89 beat Cross Country Healthcare's score of 0.23 indicating that NV5 Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NV5 Global 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cross Country Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, NVEE or CCRN? NV5 Global has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.35, meaning that its share price is 65% less volatile than the S&P 500. Do institutionals & insiders believe in NVEE or CCRN? 75.5% of NV5 Global shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 12.4% of NV5 Global shares are owned by company insiders. Comparatively, 4.9% of Cross Country Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts prefer NVEE or CCRN? NV5 Global currently has a consensus price target of $25.67, indicating a potential upside of 13.77%. Cross Country Healthcare has a consensus price target of $17.93, indicating a potential upside of 43.10%. Given Cross Country Healthcare's higher possible upside, analysts clearly believe Cross Country Healthcare is more favorable than NV5 Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NV5 Global 0 Sell rating(s) 6 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.14Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has higher earnings and valuation, NVEE or CCRN? NV5 Global has higher earnings, but lower revenue than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than NV5 Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNV5 Global$941.27M1.61$27.98M$0.5045.12Cross Country Healthcare$1.19B0.34-$14.56M-$0.26-48.19 Is NVEE or CCRN more profitable? NV5 Global has a net margin of 3.19% compared to Cross Country Healthcare's net margin of -0.70%. NV5 Global's return on equity of 9.12% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets NV5 Global3.19% 9.12% 5.84% Cross Country Healthcare -0.70%1.71%1.22% SummaryNV5 Global beats Cross Country Healthcare on 12 of the 15 factors compared between the two stocks. Get Cross Country Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for CCRN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CCRN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CCRN vs. The Competition Export to ExcelMetricCross Country HealthcareStaffing IndustryBusiness SectorNASDAQ ExchangeMarket Cap$429.46M$1.47B$20.73B$9.57BDividend YieldN/A3.53%2.83%4.18%P/E Ratio-48.1923.5727.5025.14Price / Sales0.344.3067.0897.17Price / Cash12.767.8428.1858.58Price / Book0.983.335.655.59Net Income-$14.56M$30.69M$197.12M$265.48M7 Day Performance-3.91%2.69%1.71%1.22%1 Month Performance-1.96%-4.11%-2.69%0.39%1 Year Performance-20.04%-20.10%33.78%23.47% Cross Country Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CCRNCross Country Healthcare3.6718 of 5 stars$12.53-4.4%$17.93+43.1%-20.4%$429.46M$1.19B-48.198,205Earnings ReportGap DownNVEENV5 Global3.2653 of 5 stars$22.20-1.1%$25.67+15.6%N/A$1.51B$941.27M44.855,024High Trading VolumeAMNAMN Healthcare Services4.4748 of 5 stars$17.43-2.4%$32.08+84.1%-71.8%$683.38M$2.98B-4.022,968News CoverageEarnings ReportMDPediatrix Medical Group2.8669 of 5 stars$12.32+2.8%$16.67+35.3%+50.1%$1.03B$2.01B-12.204,305Earnings ReportLHLabcorp4.8739 of 5 stars$263.82+0.9%$289.58+9.8%+18.4%$21.89B$13.01B29.1270,000Positive NewsDGXQuest Diagnostics4.7853 of 5 stars$172.60+1.0%$186.00+7.8%+19.3%$19.11B$9.87B20.6756,000Positive NewsDVADaVita4.843 of 5 stars$139.67+0.9%$167.40+19.9%-4.8%$10.46B$12.82B13.8476,000Earnings ReportAnalyst ForecastCHEChemed4.9853 of 5 stars$423.81+1.4%$579.75+36.8%-23.8%$6.11B$2.51B21.7915,695Dividend IncreaseInsider TradeCRVLCorVel1.4459 of 5 stars$86.52-0.2%N/A-11.2%$4.46B$895.59M47.115,075Earnings ReportAMEDAmedisys2.9424 of 5 stars$98.500.0%$100.50+2.0%+3.2%$3.24B$2.35B38.3319,000NSPInsperity4.2351 of 5 stars$48.20+7.0%$58.33+21.0%-43.2%$1.70B$6.58B45.484,500Trending NewsEarnings ReportInsider TradeGap UpHigh Trading Volume Related Companies and Tools Related Companies NVEE Alternatives AMN Alternatives MD Alternatives LH Alternatives DGX Alternatives DVA Alternatives CHE Alternatives CRVL Alternatives AMED Alternatives NSP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CCRN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cross Country Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cross Country Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
